220 related articles for article (PubMed ID: 11791989)
1. A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine.
Freeman AR; Lammie PJ; Houston R; LaPointe MD; Streit TG; Jooste PL; Brissau JM; Lafontant JG; Addiss DG
Am J Trop Med Hyg; 2001 Dec; 65(6):865-71. PubMed ID: 11791989
[TBL] [Abstract][Full Text] [Related]
2. Elimination of diurnally sub-periodic Wuchereria bancrofti in Andaman and Nicobar Islands, India, using mass DEC-fortified salt as a supplementary intervention to MDA.
Shriram AN; Premkumar A; Krishnamoorthy K; De A; Paul SK; Subramanian S; Vijayachari P; Jambulingam P
Parasitol Res; 2020 May; 119(5):1467-1483. PubMed ID: 32219550
[TBL] [Abstract][Full Text] [Related]
3. The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity.
Simonsen PE; Meyrowitsch DW; Mukoko DA; Pedersen EM; Malecela-Lazaro MN; Rwegoshora RT; Ouma JH; Masese N; Jaoko WG; Michael E
Am J Trop Med Hyg; 2004 Jan; 70(1):63-71. PubMed ID: 14971700
[TBL] [Abstract][Full Text] [Related]
4. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
[TBL] [Abstract][Full Text] [Related]
5. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial.
Hoti SL; Pani SP; Vanamail P; Athisaya Mary K; Das LK; Das PK
Natl Med J India; 2010; 23(2):72-6. PubMed ID: 20925201
[TBL] [Abstract][Full Text] [Related]
6. Border and imported bancroftian filariases: baseline seroprevalence in sentinel populations exposed to infections with Wuchereria bancrofti and concomitant HIV at the start of diethylcarbamazine mass treatment in Thailand.
Bhumiratana A; Koyadun S; Srisuphanunt M; Satitvipawee P; Limpairojn N; Gaewchaiyo G
Southeast Asian J Trop Med Public Health; 2005 Mar; 36(2):390-407. PubMed ID: 15916046
[TBL] [Abstract][Full Text] [Related]
7. Eradication of bancroftian filariasis by diethylcarbamazine-medicated common salt on Little Kinmen (Liehyu district), Kinmen (Quemoy) Islands, Republic of China.
Fan PC
Ann Trop Med Parasitol; 1990 Feb; 84(1):25-33. PubMed ID: 2184787
[TBL] [Abstract][Full Text] [Related]
8. Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand.
Koyadun S; Bhumiratana A; Prikchu P
Southeast Asian J Trop Med Public Health; 2003 Dec; 34(4):758-67. PubMed ID: 15115084
[TBL] [Abstract][Full Text] [Related]
9. Short report: documentation of iodine deficiency in Haitian schoolchildren: implication for lymphatic filariasis elimination in Haiti.
Beach MJ; Streit TG; Houston R; May WA; Addiss DG; Lammie PJ
Am J Trop Med Hyg; 2001; 64(1-2):56-7. PubMed ID: 11425163
[TBL] [Abstract][Full Text] [Related]
10. Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt.
Meyrowitsch DW; Simonsen PE; Makunde WH
Trans R Soc Trop Med Hyg; 1996; 90(1):74-9. PubMed ID: 8730318
[TBL] [Abstract][Full Text] [Related]
11. Salt fortified with diethylcarbamazine (DEC) as an effective intervention for lymphatic filariasis, with lessons learned from salt iodization programmes.
Houston R
Parasitology; 2000; 121 Suppl():S161-73. PubMed ID: 11386687
[TBL] [Abstract][Full Text] [Related]
12. Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme.
Ramaiah KD; Thiruvengadam B; Vanamail P; Subramanian S; Gunasekaran S; Nilamani N; Das PK
Trop Med Int Health; 2009 Aug; 14(8):870-6. PubMed ID: 19552662
[TBL] [Abstract][Full Text] [Related]
13. Short-term effects of treatment with 300 mg oral-dose diethylcarbamazine on nocturnally periodic Wuchereria bancrofti microfilaremia and antigenemia.
Siriaut C; Bhumiratana A; Koyadun S; Anurat K; Satitvipawee P
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):832-40. PubMed ID: 16295533
[TBL] [Abstract][Full Text] [Related]
14. Mass administration of DEC-medicated salt for filariasis control in the endemic population of Karaikal, south India: implementation and impact assessment.
Reddy GS; Venkateswaralu N
Bull World Health Organ; 1996; 74(1):85-90. PubMed ID: 8653820
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti.
Dreyer G; Addiss D; Williamson J; Norões J
Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1118-25. PubMed ID: 16860830
[TBL] [Abstract][Full Text] [Related]
16. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
[TBL] [Abstract][Full Text] [Related]
17. The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets.
Ramaiah KD; Vanamail P; Pani SP; Das PK
Ann Trop Med Parasitol; 2003 Oct; 97(7):737-41. PubMed ID: 14613632
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand.
Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A
J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435
[TBL] [Abstract][Full Text] [Related]
19. Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?
Shriram AN; Krishnamoorthy K; Saha BP; Roy A; Kumaraswami V; Shah WA; Jambulingam P; Vijayachari P
Parasitol Res; 2011 Jul; 109(1):1-8. PubMed ID: 21286754
[TBL] [Abstract][Full Text] [Related]
20. The efficacy, tolerability and safety of diethylcarbamazine-fortified salt in the treatment of the microfilaraemias of brugian filariasis: an open, hospital-based study.
Shenoy RK; Varghese J; Kuttikkal VV; Kumaraswami V
Ann Trop Med Parasitol; 1998 Apr; 92(3):285-93. PubMed ID: 9713544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
